FDA Approves Supplemental NDA For Ceftolozane/Tazobactam To Include Treatment Of Pediatric Complicated Intra-Abdominal Infections, Complicated Urinary Tract Infections

Infectious Disease Advisor (5/2, Park) reports the FDA “has approved the supplemental New Drug Application...for Zerbaxa® (ceftolozane and tazobactam) to include treatment of complicated intra-abdominal infections (cIAI) and complicated urinary tract infe...